Advanced Drug-Delivery Approaches in Managing P53-Mediated Lung Diseases Remodeling

NanomedicineAhead of Print CommentaryAdvanced drug-delivery approaches in managing P53-mediated lung diseases remodelingAsif Ahmad Bhat, Ritu Gilhotra, Yogendra Singh, Sanjay Sharma, Terezinha de Jesus Andreoli Pinto, Humberto Gomes Ferraz, Sachin Kumar Singh, Kamal Dua & Gaurav GuptaAsif Ahmad BhatSchool of Pharmacy, Suresh Gyan Vihar University, Jaipur, 302017, Rajasthan, IndiaSearch for more papers by this author, Ritu GilhotraSchool of Pharmacy, Suresh Gyan Vihar University, Jaipur, 302017, Rajasthan, IndiaSearch for more papers by this author, Yogendra SinghDepartment of Pharmacology, Maharishi Arvind College of Pharmacy, Ambabari Circle, Ambabari, Jaipur, 302023, IndiaSearch for more papers by this author, Sanjay SharmaShobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM’S NMIMS, V. L. Mehta Road, Vile Parle (W), Mumbai, 400056, IndiaSearch for more papers by this author, Terezinha de Jesus Andreoli Pinto https://orcid.org/0000-0002-0238-8227Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, Professor Lineu Prestes Street, São Paulo, 05508-000, BrazilSearch for more papers by this author, Humberto Gomes FerrazDepartment of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, Professor Lineu Prestes Street, São Paulo, 05508-000, BrazilSearch for more papers by this author, Sachin Kumar SinghSchool of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, IndiaFaculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, NSW, 2007, AustraliaSearch for more papers by this author, Kamal Dua https://orcid.org/0000-0002-7507-1159Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology Sydney, Ultimo, NSW, 2007, AustraliaDiscipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, 2007, AustraliaSearch for more papers by this author & Gaurav Gupta *Author for correspondence: E-mail Address: gauravpharma25@gmail.comhttps://orcid.org/0000-0001-7941-0229School of Pharmacy, Suresh Gyan Vihar University, Jaipur, 302017, Rajasthan, IndiaDepartment of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical & Technical Sciences, Saveetha University, Chennai, 602105, IndiaUttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, 248007, IndiaSearch for more papers by this authorPublished Online:17 May 2023https://doi.org/10.2217/nnm-2023-0032AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: asthmachronic obstructive pulmonary diseasedrug deliveryinflammationlunglung cancerlung injurynanoparticleP53pulmonary fibrosisReferences1. Kim M, Vu NT, Wang X et al. Caspase 9b drives cellular transformation, lung inflammation, and lung tumorigenesis. Mol. Cancer. Res. 20(8), 1284–1294 (2022).Crossref, Medline, CAS, Google Scholar2. Nakano-Narusawa Y, Yokohira M, Yamakawa K et al. Relationship between lung carcinogenesis and chronic inflammation in rodents. Cancers (Basel) 13(12), 2910 (2021).Crossref, Medline, CAS, Google Scholar3. Barnes PJ, Baker J, Donnelly LE. Cellular senescence as a mechanism and target in chronic lung diseases. Am. J. Respir. Crit. Care Med. 200(5), 556–564 (2019).Crossref, Medline, CAS, Google Scholar4. Bhattarai N, Wang J, Nguyen D et al. Nanoparticle encapsulation of non-genotoxic p53 activator inauhzin-C for improved therapeutic efficacy. Theranostics 11(14), 7005–7017 (2021).Crossref, Medline, CAS, Google Scholar5. Liu Y, Hu F, Zhao L. Effect of nano-platinum on proliferation and apoptosis of non-small-cell lung cancer cells via P53 pathway. J. Nanosci. Nanotechnol. 21(2), 903–908 (2021).Crossref, Medline, CAS, Google Scholar6. Teng C, Li B, Lin C et al. Targeted delivery of baicalein-p53 complex to smooth muscle cells reverses pulmonary hypertension. J. Control. Rel. 341, 591–604 (2022).Crossref, Medline, CAS, Google Scholar7. Gautam A, Densmore C, Waldrep J. Inhibition of experimental lung metastasis by aerosol delivery of PEI–p53 complexes. Mol. Ther. 2, 318–323 (2000).Crossref, Medline, CAS, Google Scholar8. Choi SH, Jin SE, Lee MK et al. Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells. Eur. J. Pharm. Biopharm. 68(3), 545–554 (2008).Crossref, Medline, CAS, Google Scholar9. Guo C, Wang J, Yang M et al. Amorphous silica nanoparticles induce malignant transformation and tumorigenesis of human lung epithelial cells via P53 signaling. Nanotoxicology 11(9–10), 1176–1194 (2017).Crossref, Medline, CAS, Google Scholar10. Wang MS, Chen L, Xiong YQ, Xu J, Wang JP, Meng ZL. Iron oxide magnetic nanoparticles combined with actein suppress non-small-cell lung cancer growth in a p53-dependent manner. Int. J. Nanomed. 12, 7627–7651 (2017).Crossref, Medline, CAS, Google Scholar11. Blanco J, Lafuente D, Gómez M, García T, Domingo JL, Sánchez DJ. Polyvinyl pyrrolidone-coated silver nanoparticles in a human lung cancer cells: time- and dose-dependent influence over p53 and caspase-3 protein expression and epigenetic effects. Arch. Toxikol. 91(2), 651–666 (2017).Crossref, CAS, Google Scholar12. Kang K, Jung H, Lim JS. Cell death by polyvinylpyrrolidine-coated silver nanoparticles is mediated by ROS-dependent signaling. Biomol. Ther. (Seoul) 20(4), 399–405 (2012).Crossref, Medline, CAS, Google Scholar13. Noorbazargan H, Amintehrani S, Dolatabadi A et al. Anti-cancer & anti-metastasis properties of bioorganic-capped silver nanoparticles fabricated from Juniperus chinensis extract against lung cancer cells. AMB Express. 11(1), 61 (2021).Crossref, Medline, CAS, Google Scholar14. Gu L, Deng ZJ, Roy S, Hammond PT. A combination RNAi-chemotherapy layer-by-layer nanoparticle for systemic targeting of KRAS/P53 with cisplatin to treat non-small-cell lung cancer. Clin. Cancer Res. 23(23), 7312–7323 (2017).Crossref, Medline, CAS, Google Scholar15. Guo Q, Kong F, Pan X, Cao S. Co-delivery of docetaxel and p53 gene from cationic nanoparticles based on poly (l-lactide) and low-molecular-weight polyethyleneimine (PEA). Pharm. Dev. Technol. 27(10), 1049–1056 (2022).Crossref, Medline, CAS, Google Scholar16. Moro M, Di Paolo D, Milione M et al. Coated cationic lipid-nanoparticles entrapping miR-660 inhibit tumor growth in patient-derived xenografts lung cancer models. J. Control. Rel. 308, 44–56 (2019).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetails Ahead of Print STAY CONNECTED Metrics Downloaded 0 times History Received 8 February 2023 Accepted 11 April 2023 Published online 17 May 2023 Information© 2023 Future Medicine LtdKeywordsasthmachronic obstructive pulmonary diseasedrug deliveryinflammationlunglung cancerlung injurynanoparticleP53pulmonary fibrosisFinancial & competing interests disclosureThe authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending or royalties.No writing assistance was utilized in the production of this manuscript.PDF download